CD11b+CD11c+-Mediated GVHD Inhibition Does Not Prevent Expansion and Homing of Allogeneic T Cells In Vivo But Requires Induction of Type 2 Immunity. The gene discussed is ITGAM; the disease is graft versus host disease.